Interviews

Kalin M. Clifford, PharmD, BCPS, discusses the factors should be considered when determining whether or not a patient with advanced dementia should continue taking a memantine or cholinesterase inhibitor.

Mark Parkinson, CEO of the American Health Care Association, discusses challenges and opportunities that consultant pharmacists might encounter in the post-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses potential changes that may occur in the post-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses how the roles and responsibilities of pharmacists might evolve in response to recent changes within the past-acute care industry.

Mark Parkinson, CEO of the American Health Care Association, discusses how recent changes within the post-acute care industry might benefit or hinder pharmacists.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses how consultant pharmacists and provider organizations can help one another to achieve their respective objectives.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses the ways in which provider organizations have attempted to manage risk.

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, discusses how the objectives of consultant pharmacists differ from those of provider organizations.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the rewards and challenges of treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the drugs that should be used cautiously when treating geriatric patients.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the reasons for the recent changes made to the American Geriatrics Society Beers Criteria.

Todd Semla, MS, PharmD, BCPS, AGSF, of the Department of Veterans Affairs discusses the recent changes made to the American Geriatrics Society Beers Criteria.

Elias Cachine, PharmD, discusses how pharmacists can prevent inappropriate antimicrobial use.

Elias Cachine, PharmD, discusses the factors that can potentially contribute to antimicrobial overuse in geriatric patients.

Elias Cachine, PharmD, discusses the potential complications that can arise as a result of antibiotic overuse in geriatric patients.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the pharmacist's role in treating patients who are experiencing renal impairment.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses ways to avoid unintentional errors in renal dose adjustments.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the best methods to use to estimate creatinine clearance levels.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the potential complications that can arise from improper renal dosing.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the factors that contribute to inappropriate renal dosing.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about how to market traveling services at a pharmacy.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how the Pharmacy Disaster Support Center can help pharmacists.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, shares information on the current and future estimates of e-prescribing use.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about what makes patients loyal to one pharmacy.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, Inc, discusses how the ACA has impacted the specialty landscape.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some safeguards independent pharmacies can implement to avoid issues with controlled substance prescriptions.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, talks about important health care quality metrics for pharmacists and comments on how pharmacists can be active in driving value-based reimbursement.

Elias Cachine, PharmD, BCPS (AQ-10) explains what steps pharmacists should take when treating infections in geriatric patients.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses what happens to a pharmacy if it is found to be out of compliance with DEA regulations or federal statutes.

Ryan Nolan, PharmD, MBA, CSP, clinical services manager at Diplomat, discusses ongoing lessons from the market reaction to high cost hepatitis C treatments.